Is Raw Pharma Oxythol Oxymetholone appropriate for professional competitive bodybuilders?

Yes — Oxythol is specifically formulated at 50 mg per tablet to meet the dosing architecture used by professional competitors in contest preparation phases. Its HPLC-verified API content provides the per-tablet accuracy that elite athletes require when precise dosing during peak week is non-negotiable. It is not intended for novice or first-cycle users.

What protocols do experienced professional athletes typically structure around a 50 mg Oxymetholone tablet?

Experienced competitors generally position Oxymetholone within a defined four-week pre-contest window, running 50 mg daily as the oral component of a broader injectable-anchored stack. The 50 mg tablet unit aligns exactly with the standard professional daily reference dose, making each administration a single analytically confirmed unit — a critical attribute when protocol reproducibility is the goal.

What physiological markers do elite bodybuilders track specifically when using Oxymetholone in contest prep?

Professional athletes monitor ALT and AST by enzymatic assay at baseline, at the two-week mark, and at cessation. Haematocrit — assessed by standard venous draw — is tracked because Oxymetholone elevates red-cell mass via an erythropoietin-mediated pathway; most experienced competitors establish a personal ceiling around 52–54 % to protect cardiovascular output during peak training loads.

Can the 50 mg tablets in Oxythol be split for lower-dose professional protocols?

Splitting is mechanically possible but not recommended when API content uniformity is a priority. Raw Pharma's Oxythol tablets are compressed to a uniform 50 mg specification; splitting introduces potential for unequal API distribution between halves. Professionals who require sub-50 mg increments are better served by sourcing a separately verified lower-dose unit rather than dividing a 50 mg tablet.

Why does the 50 mg-per-tablet concentration make Oxythol a preferred choice among advanced users compared to lower-concentration options?

The 50 mg concentration represents the standard professional reference dose in a single tablet, eliminating the need to combine multiple lower-dose units and the cumulative measurement variability that introduces. For advanced users whose protocols are built around precise dose-to-injectable-compound ratios, receiving the full daily oral androgen load from one analytically verified tablet preserves the pharmacological ratio planned at protocol design. (2) angle_used

Competition Proven

Raw Pharma

Oxythol 50mg/tab 50 Tabletten by Raw Pharma

Name: Oxythol 50mg/tab 50 Tablets by Raw Pharma
Brand: Raw Pharma
SKU: ORA-OXYM-RAW-020
Price: 46.00 EUR
Availability: InStock

Oxythol by Raw Pharma is a 50 mg-per-tablet oral Oxymetholone product in a 50-tablet pack, built to serve the demands of serious competitive athletes who require an analytically verified oral androgen calibrated to professional-level performance standards. The 50-tablet count aligns directly with a defined four-week pre-event window at 50 mg daily, giving practitioners a clean, zero-surplus supply for one complete professional dosing cycle. Release quality is enforced through HPLC quantification of finished-tablet API content and LAL endotoxin screening applied to raw Oxymetholone material prior to any compression step — ensuring that each tablet carries a traceable, batch-specific analytical record.

€46.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

50 mg per tablet aligns with the standard professional daily reference dose as a single verified unit
HPLC content assay on every production batch confirms API accuracy before tablets enter circulation
LAL endotoxin screening on incoming Oxymetholone API eliminates pyrogenic contamination risk at the source
50-tablet pack count maps exactly to a 50-day supply at 50 mg daily — zero leftover tablets, clean protocol completion
Erythropoietic output measurably elevates red-cell mass, supporting vascular fullness under stage lighting
Pronounced nitrogen-retention signal contributes to lean-mass preservation during the highest-demand pre-contest phase
Tablet format allows straightforward integration into multi-compound professional stacks without injectable vehicle considerations

Phase	Dosage	Note
Entry / Biomarker Baseline	25 mg/day	First 7 days — establish ALT, AST, and haematocrit reference values before advancing to professional dose; tablet may be taken as half a 50 mg unit if a separate lower-dose product is unavailable
Active Professional Dose	50 mg/day	Weeks 2–4 — single 50 mg tablet daily timed relative to the primary training session; do not extend beyond four continuous weeks without biomarker review
Cessation / Bridge	25 mg/day (optional taper)	Final 3–5 days — optional step-down to reduce abrupt androgenic withdrawal effect; requires tablet splitting or supplementary low-dose unit; injectable stack continues per its own protocol

Key takeaways

Select Oxythol when a 50 mg single-tablet professional dosing standard is required.
Monitor ALT, AST, and haematocrit at two-week intervals throughout every cycle.
Verify batch HPLC documentation before integrating any oral androgen into contest prep.
Position Oxymetholone within a four-week pre-event window for controlled peak timing.
Match pack size to cycle length — 50 tablets equals exactly 50 days at 50 mg.

Oxythol: A Professional-Grade Oxymetholone Tablet for Elite Contest Preparation

Oxythol is a 50 mg-per-tablet oral Oxymetholone formulation designed around the biological and logistical demands of professional-level bodybuilding, where the margin between a podium finish and a missed peak is frequently measured in the precision of the final preparation phase. Professional competitors require tools that perform predictably under the highest physiological stress, and the 50 mg tablet concentration directly supports that standard. Raw Pharma produces Oxythol to a consistent API content specification verified by HPLC quantification, establishing a traceable quality record for every batch that reaches the competitive athlete.

Why Experienced Competitors Choose a 50 mg Oxymetholone Standard

Professional bodybuilders apply Oxymetholone differently from general-population performance users: the compound is positioned as a precision instrument within a broader pharmacological architecture rather than as the sole anabolic driver. Oxymetholone delivers a pronounced erythropoietic signal — measurably elevating red-cell mass as assessed by haematocrit monitoring — which translates to increased oxygen-carrying capacity and a fuller, more vascular muscular appearance under stage conditions. Compared to lower-dose oral androgens used in professional contest prep, Oxymetholone at the 50 mg reference dose produces a more rapid and visible volumising effect per unit of protocol time, which experienced athletes factor precisely into their peak-week scheduling.

What Professional Athletes Monitor During a High-Dose Oral Androgen Phase

Professional use of Oxymetholone demands structured biomarker monitoring that goes beyond what recreational users typically implement. Hepatic enzyme panels — specifically ALT and AST measured by standard enzymatic assay — are reviewed at baseline, at two weeks, and at cycle end; experienced practitioners treat any reading that exceeds three times the upper reference limit as a mandatory dose-adjustment signal rather than an observation point. Haematocrit values are tracked by standard venous blood draw because Oxymetholone drives red-cell production through an erythropoietin-mediated mechanism; elite competitors set a personal ceiling — typically 52–54 % — above which they reduce exposure to protect cardiovascular work efficiency under peak-load training. Raw Pharma documents microbial and endotoxin status on each Oxythol batch through LAL testing on incoming API, ensuring that the tablet entering a professional's protocol carries no pyrogenic contaminant load that could compromise training continuity.

Professional Protocol Architecture

Elite competitors typically nest Oxythol within a four-week active window positioned at the most strategically demanding phase of their annual calendar. The 50-tablet pack provides exactly 50 daily doses at the standard professional reference of 50 mg per day — a deliberate pack-size alignment that eliminates leftover tablets and supports clean protocol completion without mid-cycle reordering. Experienced athletes who have used multiple Oxymetholone sources consistently rate per-tablet uniformity as the highest-priority quality attribute, since inconsistent API distribution across tablets directly undermines the dose-response predictability that professional preparation depends upon.

Usage

Confirm baseline hepatic enzyme panel (ALT, AST) and haematocrit by standard venous blood draw before taking the first tablet.
Begin Oxythol only within an established injectable androgen cycle — Oxymetholone is a professional oral androgen positioned as a precision tool within a broader stack, not a standalone compound.
Administer the 50 mg tablet orally with a moderate-volume meal (approximately 20–25 g fat) to support gastric tolerance without significantly delaying absorption toward the training window.
Schedule the tablet 60–90 minutes before the primary training session during the active dosing phase to align peak plasma exposure with the maximal mechanical stimulus.
Repeat hepatic enzyme and haematocrit assessment at the two-week mark; reduce dose or discontinue if ALT or AST exceeds three times the upper reference limit, or if haematocrit surpasses your individually defined ceiling.
On rest days, maintain the same single daily dose in the morning to preserve consistent daily androgen exposure; do not skip doses to compensate for previous days.

Warnings

Contraindications: Oxythol is contraindicated in individuals with pre-existing liver disease or elevated hepatic enzymes confirmed on laboratory assay, active or unmanaged cardiovascular pathology, polycythaemia vera or secondary erythrocytosis, and documented hypersensitivity to Oxymetholone or any tablet excipient. Use is restricted to adult males with established multi-cycle experience operating under medical or specialist supervision; it is not appropriate for women, adolescents, or first-cycle users.

Side_Effects: Adverse effects associated with Oxymetholone include hepatocellular stress expressed as ALT and AST elevation — a consequence of the 17α-alkyl modification required for oral bioavailability — alongside secondary erythrocytosis quantifiable by rising haematocrit on routine CBC. Androgenic sequelae in susceptible individuals include accelerated scalp-hair thinning and sebaceous gland hyperactivity. Lipid-panel disruption — characterised by rising LDL and falling HDL — represents a cardiovascular risk factor requiring monitoring throughout use. Intracellular fluid accumulation may produce transient bodyweight increases disproportionate to lean-tissue gain. Despite the absence of direct aromatisation due to the DHT-derived structure, progestogenic receptor interaction may elevate gynecomastia susceptibility independent of oestrogen conversion.

Monitoring: A full blood panel — encompassing ALT, AST, total bilirubin, CBC inclusive of haematocrit, and a lipid profile — is mandatory at three points: before the first dose, at the mid-cycle two-week interval, and at protocol cessation. Daily self-monitored blood pressure readings are advised throughout the active oral androgen window. A haematocrit value exceeding 54 % on any single assessment requires immediate dose reduction and prompt clinical consultation before resuming any oral androgen exposure.

PCT: Oxythol exerts suppressive pressure on the hypothalamic-pituitary-gonadal axis proportional to dose and duration. Endogenous testosterone recovery requires a structured SERM-based restoration protocol — Tamoxifen or Clomiphene are the established agents — initiated according to injectable ester clearance timing rather than the date of the final oral tablet. Users maintained on continuous TRT or a cruise phase should manage the Oxymetholone window as an overlay within that framework rather than initiating standalone PCT.

Frequently asked questions

Is Raw Pharma Oxythol Oxymetholone appropriate for professional competitive bodybuilders?: Yes — Oxythol is specifically formulated at 50 mg per tablet to meet the dosing architecture used by professional competitors in contest preparation phases. Its HPLC-verified API content provides the per-tablet accuracy that elite athletes require when precise dosing during peak week is non-negotiable. It is not intended for novice or first-cycle users.
What protocols do experienced professional athletes typically structure around a 50 mg Oxymetholone tablet?: Experienced competitors generally position Oxymetholone within a defined four-week pre-contest window, running 50 mg daily as the oral component of a broader injectable-anchored stack. The 50 mg tablet unit aligns exactly with the standard professional daily reference dose, making each administration a single analytically confirmed unit — a critical attribute when protocol reproducibility is the goal.
What physiological markers do elite bodybuilders track specifically when using Oxymetholone in contest prep?: Professional athletes monitor ALT and AST by enzymatic assay at baseline, at the two-week mark, and at cessation. Haematocrit — assessed by standard venous draw — is tracked because Oxymetholone elevates red-cell mass via an erythropoietin-mediated pathway; most experienced competitors establish a personal ceiling around 52–54 % to protect cardiovascular output during peak training loads.
Can the 50 mg tablets in Oxythol be split for lower-dose professional protocols?: Splitting is mechanically possible but not recommended when API content uniformity is a priority. Raw Pharma's Oxythol tablets are compressed to a uniform 50 mg specification; splitting introduces potential for unequal API distribution between halves. Professionals who require sub-50 mg increments are better served by sourcing a separately verified lower-dose unit rather than dividing a 50 mg tablet.
Why does the 50 mg-per-tablet concentration make Oxythol a preferred choice among advanced users compared to lower-concentration options?: The 50 mg concentration represents the standard professional reference dose in a single tablet, eliminating the need to combine multiple lower-dose units and the cumulative measurement variability that introduces. For advanced users whose protocols are built around precise dose-to-injectable-compound ratios, receiving the full daily oral androgen load from one analytically verified tablet preserves the pharmacological ratio planned at protocol design. (2) angle_used

Manufacturer

Raw Pharma's approach to microbial purity and endotoxin control in its Oxythol tablet line operates at the API intake stage rather than being deferred to finished-product release testing alone. Incoming Oxymetholone active pharmaceutical ingredient is subjected to LAL (Limulus Amebocyte Lysate) endotoxin assay before it is transferred to the blending and compression environment — a sequencing decision that prevents contaminated API from entering the tablet matrix in the first place. Bioburden evaluation of compression room surfaces and tooling follows an independently scheduled interval-testing protocol, with environmental monitoring data retained on file alongside the lot-specific HPLC content report for each batch of Oxythol released. The finished tablet is released only after the API-level endotoxin data, the environmental bioburden records, and the HPLC quantification against the declared 50 mg per tablet specification are reviewed as a unified batch record — not as isolated checkpoints — making microbial and chemical quality mutually confirmatory rather than sequentially optional.

Product details

Brand	Raw Pharma
Active ingredient	oxymetholone
Also known as	Anadrol, Anapolon, Oxymetholone, Oxythol, Raw Pharma Anadrol
Strength	50 mg
Form	Tabletten
Pack size	50 pieces
Item number	ORA-OXYM-RAW-020

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Anapolon 50mg/tab 20 Tablets by Abdi Ibrahim

Lab Tested

Anapolon 50mg/tab 20 Tabletten by Abdi Ibrahim

Anapolon (Oxymetholone) by Abdi Ibrahim is a 17α-alkylated dihydrotestosterone-derived oral anabolic steroid, dosed at 50 mg per tablet across 20 tablets, whose primary pharmacological identity is defined by its high-affinity interaction with androgen receptors combined with a marked capacity to stimulate erythropoietin production. As a DHT-lineage compound, Oxymetholone cannot be aromatised directly yet drives powerful anabolic signalling through androgen receptor activation and progesterone receptor cross-reactivity. Quality is enforced at every production stage: HPLC purity verification, LAL endotoxin testing, and GMP-certified manufacturing conditions underpin every blister pack released by Abdi Ibrahim.

€20.00

Anapolon 50mg/tab 60 Tablets by Balkan Pharmaceuticals

HPLC Verified

Anapolon 50mg/tab 60 Tabletten by Balkan Pharmaceuticals

Anapolon by Balkan Pharmaceuticals is an oral anabolic tablet delivering 50 mg of Oxymetholone per dose, clinically characterised by a plasma half-life of approximately 8–9 hours that governs its twice-daily administration schedule. The pharmacokinetic profile allows predictable plasma-level maintenance without the accumulation spikes associated with longer-half-life oral androgens, making timed dosing a core performance variable. Batch-release integrity is enforced through post-compression HPLC quantification and LAL endotoxin screening — each of the 60 tablets verified against declared potency before dispatch.

€48.00

Pro-Anadrol 50mg/tab 50 Tablets by Beligas Pharmaceuticals

Pharma Grade

Pro-Anadrol 50mg/tab 50 Tabletten by Beligas Pharmaceuticals

Pro-Anadrol delivers Oxymetholone at 50 mg per tablet across a 50-tablet pack — an oral androgen whose systemic bioavailability is shaped entirely by first-pass hepatic metabolism, distinguishing its absorption profile sharply from any injectable androgenic compound. Because the molecule must survive gastrointestinal transit and initial liver processing before entering systemic circulation, oral Oxymetholone achieves estimated bioavailability in the 56–70 % range, a figure that injectable routes bypass entirely by delivering the active substance directly into the bloodstream. Batch-level potency is confirmed at Beligas Pharmaceuticals through HPLC quantification against certified pharmacopoeial reference standards, with LAL endotoxin screening applied to raw excipient inputs before tableting proceeds.

€60.00

OxyTrex 25mg/tab 100 Tablets by Concentrex Labs

Purity Tested

OxyTrex 25mg/tab 100 Tabletten by Concentrex Labs

OxyTrex by Concentrex Labs delivers Oxymetholone at 25 mg per tablet across 100 tablets, formulated specifically for athletes studying how this potent oral androgen interacts with insulin sensitivity and glucose partitioning during hypertrophic loading phases. Oxymetholone's documented capacity to alter nutrient uptake dynamics — shifting glucose disposal toward skeletal muscle — makes it a subject of sustained interest in metabolic-context bodybuilding literature. Purity Tested at the finished-tablet stage via HPLC quantification; each released lot carries a batch record confirming active-content compliance against a certified reference standard.

€60.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00